Sze H - Search Results

1

Is selective neck irradiation safe for node-negative nasopharyngeal carcinoma?

Lee AW, Sze H, Ng WT. Lee AW, et al. Among authors: sze h. Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):902-3. doi: 10.1016/j.ijrobp.2012.09.010. Int J Radiat Oncol Biol Phys. 2013. PMID: 23452454 No abstract available.

2

The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement.

Lee AWM, Ng WT, Chan LK, Chan OSH, Hung WM, Chan CC, Cheng PTC, Sze H, Lam TS, Yau TK. Lee AWM, et al. Among authors: sze h. Oral Oncol. 2012 Oct;48(10):1007-1013. doi: 10.1016/j.oraloncology.2012.03.022. Epub 2012 Apr 22. Oral Oncol. 2012. PMID: 22525607

3

Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?

Sze H, Chan LL, Ng WT, Hung AW, Lee MC, Chang AT, Chan OS, Cheung FY, Yeung RM, Lee AW. Sze H, et al. Oral Oncol. 2014 Dec;50(12):1188-95. doi: 10.1016/j.oraloncology.2014.09.001. Epub 2014 Sep 30. Oral Oncol. 2014. PMID: 25261296

4

Trends and patterns of breast conservation treatment in Hong Kong: 1994-2007.

Yau TK, Soong IS, Sze H, Choi CW, Yeung MW, Ng WT, Lee AW. Yau TK, et al. Among authors: sze h. Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):98-103. doi: 10.1016/j.ijrobp.2008.07.066. Epub 2008 Dec 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19101091

5

A tale of two cities in China: Hong Kong and Shenzhen.

Lee AW, Sze H, Lam KO, Chen X. Lee AW, et al. Among authors: sze h. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):704-8. doi: 10.1016/j.ijrobp.2013.12.053. Int J Radiat Oncol Biol Phys. 2014. PMID: 24969788 No abstract available.

6

Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies.

Sze H, Blanchard P, Ng WT, Pignon JP, Lee AW. Sze H, et al. Hematol Oncol Clin North Am. 2015 Dec;29(6):1107-22. doi: 10.1016/j.hoc.2015.07.004. Epub 2015 Oct 20. Hematol Oncol Clin North Am. 2015. PMID: 26568551 Review.

7

The battle against nasopharyngeal cancer.

Lee AW, Ng WT, Chan YH, Sze H, Chan C, Lam TH. Lee AW, et al. Among authors: sze h. Radiother Oncol. 2012 Sep;104(3):272-8. doi: 10.1016/j.radonc.2012.08.001. Epub 2012 Aug 30. Radiother Oncol. 2012. PMID: 22938727 Review.

8

HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays.

Yau TK, Sze H, Soong IS, Hioe F, Khoo US, Lee AW. Yau TK, et al. Among authors: sze h. Hong Kong Med J. 2008 Apr;14(2):130-5. Hong Kong Med J. 2008. PMID: 18382020 Free article.

9

Should young age be a contra-indication to breast conservation treatment in Chinese women? Twelve-year experience from a public cancer centre in Hong Kong.

Yau TK, Choi CW, Sze H, Soong IS, Lee AW. Yau TK, et al. Among authors: sze h. Hong Kong Med J. 2009 Apr;15(2):94-9. Hong Kong Med J. 2009. PMID: 19342734 Free article.

10

Evaluation of the prognostic value of 2005 St Gallen risk categories for operated breast cancers in Hong Kong.

Yau TK, Soong IS, Chan K, Chang A, Sze H, Yeung MW, Tung R, Lau S, Lee A. Yau TK, et al. Among authors: sze h. Breast. 2008 Feb;17(1):58-63. doi: 10.1016/j.breast.2007.06.007. Epub 2007 Sep 4. Breast. 2008. PMID: 17804235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page